Condition Genetics Hub

Long COVID refers to persistent symptoms lasting weeks or months after acute SARS-CoV-2 infection. Research suggests genetic factors may influence who develops Long COVID and the severity and duration of symptoms.

Chronic inflammation is a persistent, low-grade inflammatory state linked to numerous conditions including Long COVID, ME/CFS, autoimmunity, and cardiovascular disease. Genetic variants in cytokine and immune signalling genes may influence individual inflammatory responses.

Immune dysregulation describes a state where the immune system fails to mount appropriate, balanced responses — either overreacting, underreacting, or failing to resolve inflammation appropriately. It is central to Long COVID, ME/CFS, and autoimmune conditions.

Mitochondrial dysfunction refers to impaired cellular energy production through the mitochondrial respiratory chain. It is a key mechanism studied in Long COVID, ME/CFS, and chronic fatigue, where patients report profound and persistent energy impairment.

Neurological symptoms including brain fog, cognitive impairment, neuropathy, and neuroinflammation are among the most debilitating features of Long COVID and ME/CFS. Genetic variants in neuroinflammatory, neurotransmitter, and neuroprotective pathways may influence individual neurological vulnerability.

Autoimmunity occurs when the immune system mistakenly attacks the body's own tissues. Genetic predisposition plays a major role in autoimmune conditions, and overlaps with Long COVID and ME/CFS where autoantibodies have been identified.

ME/CFS is a complex, chronic illness characterised by profound fatigue, post-exertional malaise, cognitive impairment, and autonomic dysfunction. Genetic research into ME/CFS overlaps extensively with Long COVID, sharing common immune, mitochondrial, and autonomic pathways.

Chronic pain is a common and debilitating feature of Long COVID, ME/CFS, fibromyalgia, and connective tissue disorders. Genetic variants in pain perception, neuroinflammation, and sensory neuron genes may influence individual pain thresholds and central sensitisation.

Cardiovascular involvement is documented in Long COVID, including cardiac arrhythmias, myocarditis, autonomic dysfunction, and elevated clotting risk. Genetic variants in cardiac, vascular, and coagulation pathways may influence individual cardiovascular vulnerability.

Respiratory symptoms including breathlessness, reduced lung capacity, and pulmonary fibrosis are reported in Long COVID and post-viral illness. Genetic variants in pulmonary function, mucosal immunity, and airway inflammation genes may influence respiratory outcomes.

POTS (Postural Orthostatic Tachycardia Syndrome) and dysautonomia involve dysfunction of the autonomic nervous system, causing abnormal heart rate and blood pressure responses. POTS is among the most commonly reported Long COVID conditions and has genetic contributors.

Brain fog is one of the most commonly reported and debilitating symptoms of Long COVID and ME/CFS, encompassing cognitive slowing, memory difficulties, word-finding problems, and impaired concentration. Genetic variants in neuroinflammatory, neurotransmitter, and neurovascular pathways may influence brain fog susceptibility.

Fatigue is the most prevalent symptom of Long COVID and ME/CFS. Genetic variants in mitochondrial energy, HPA axis function, neurotransmitter systems, and immune activation pathways may all contribute to individual differences in fatigue severity and persistence.

Gastrointestinal symptoms including nausea, bloating, altered motility, and gut dysbiosis are reported in Long COVID and ME/CFS. Genetic variants in gut barrier integrity, mucosal immunity, and gut-brain axis regulation may influence GI vulnerability.

Connective tissue disorders including hypermobile Ehlers-Danlos Syndrome (hEDS) and hypermobility spectrum disorders frequently co-occur with ME/CFS, POTS, and MCAS. Genetic variants in collagen, elastin, and extracellular matrix genes underlie connective tissue integrity.

Mast Cell Activation Syndrome (MCAS) involves inappropriate or excessive activation of mast cells, releasing histamine and other mediators. MCAS overlaps significantly with Long COVID, ME/CFS, and connective tissue disorders, and has both genetic and immune-mediated contributors.

Neuroinflammation involves activation of microglia and astrocytes within the central nervous system, driving brain inflammation. It is a proposed mechanism underlying brain fog, cognitive impairment, and neurological symptoms in Long COVID and ME/CFS.

Cognitive dysfunction including impaired memory, attention, executive function, and processing speed is a defining feature of Long COVID and ME/CFS. Genetic variants in neurotransmitter systems, neuroplasticity, and cerebrovascular regulation may influence cognitive resilience.

Allergic conditions including asthma, eczema, hay fever, and food allergy reflect dysregulated type 2 immune responses. Genetic variants in IgE regulation, cytokine pathways, and epithelial barrier genes influence atopic predisposition and allergy severity.

Dysautonomia encompasses a range of conditions involving autonomic nervous system dysfunction, including POTS, orthostatic hypotension, and vagal dysfunction. It is among the most common Long COVID presentations and has both genetic and autoimmune contributors.

Methylation is a fundamental biochemical process supporting DNA repair, neurotransmitter synthesis, detoxification, and gene expression regulation. MTHFR and related gene variants are among the most commonly discussed genetic variants in chronic illness communities.

Unrefreshing sleep and sleep disturbances are hallmark features of ME/CFS and Long COVID. Genetic variants in circadian rhythm regulation, sleep architecture genes, and neurotransmitter systems may influence sleep quality and susceptibility to sleep dysfunction in chronic illness.

Coagulopathy refers to impaired blood clotting regulation, encompassing both hypercoagulable states (increased clotting risk) and hypocoagulable states (bleeding tendency). Post-COVID coagulopathy including microclotting and fibrinogen abnormalities has been extensively documented.

Gut health encompasses intestinal microbiome balance, mucosal immunity, barrier integrity, and digestive function. The gut microbiome is significantly disrupted in Long COVID, and genetic variants influencing host-microbiome interactions may affect recovery.

Histamine intolerance involves symptoms triggered by histamine accumulation — either from dietary sources, mast cell release, or impaired histamine degradation. Genetic variants in DAO and HNMT enzymes that degrade histamine are central to histamine intolerance biology.

Mast cell activation syndrome involves recurrent, inappropriate mast cell degranulation causing multisystem symptoms. Overlapping with the mcas condition entry, this provides the formal syndrome-level view with clinical context and diagnostic framework.

Cardiac arrhythmias — abnormal heart rhythm disturbances — are among the documented cardiovascular complications of Long COVID. Genetic variants in cardiac ion channels, gap junctions, and autonomic regulators may predispose individuals to arrhythmia under the inflammatory and autonomic stress of post-COVID illness.

Mood disturbances including depression, anxiety, and emotional dysregulation are common in Long COVID and ME/CFS. Genetic variants in serotonin, dopamine, and stress response pathways interact with chronic illness biology to influence mental health outcomes.

Autonomic dysfunction encompasses a broad range of impairments to the autonomic nervous system regulating heart rate, blood pressure, digestion, and other involuntary functions. It is a central feature of Long COVID, POTS, and ME/CFS.

Type I interferonopathies are conditions characterised by chronic upregulation of type I interferon signalling, driving systemic inflammation. A subset of Long COVID patients show interferon signature patterns suggesting interferonopathy-like pathology.

Insulin resistance is a condition where cells fail to respond normally to insulin, leading to elevated blood glucose, compensatory hyperinsulinaemia, and metabolic dysfunction. Genetic variants in insulin signalling, glucose transport, and pancreatic beta-cell function contribute to insulin resistance risk.

Anxiety disorders involve dysregulated fear and stress responses, mediated by neurotransmitter systems, HPA axis activity, and neurological circuits. Genetic variants in serotonin, GABA, noradrenaline, and stress hormone pathways may influence anxiety susceptibility.

Thrombosis involves abnormal blood clot formation within vessels, driven by hypercoagulability, endothelial dysfunction, and impaired fibrinolysis. Genetic variants in clotting factors — particularly F5 (Factor V Leiden) and F2 (prothrombin G20210A) — substantially increase thrombotic risk.

Anaemia involves reduced haemoglobin or red blood cell capacity, with genetic variants influencing iron absorption, utilisation, red cell production, and haemoglobin structure. Functional iron deficiency is common in chronic illness including Long COVID.

Metabolic dysfunction encompasses impaired energy metabolism, lipid handling, glucose regulation, and mitochondrial function. Genetic variants across multiple metabolic pathways contribute to metabolic syndrome risk and may influence chronic illness outcomes.

Cognitive function involves attention, working memory, executive function, and information processing speed. Brain fog — a common Long COVID symptom — reflects impaired cognitive function with neuroinflammatory, vascular, and neurotransmitter mechanisms that may be modulated by genetic variants.

Thyroid hormones regulate metabolism, energy production, cardiac function, and cognitive function. Genetic variants in thyroid hormone synthesis, receptor, and autoimmunity genes influence thyroid function and risk of hypothyroidism, hyperthyroidism, and thyroid autoimmune disease.

Diabetes encompasses type 1 (autoimmune beta-cell destruction) and type 2 (progressive insulin resistance and beta-cell dysfunction). Both have strong genetic components, with HLA genes dominating type 1 risk and common metabolic variants contributing to type 2 risk.

Gut dysbiosis — an imbalanced gut microbiome — is associated with Long COVID, ME/CFS, inflammatory bowel disease, and mental health conditions. Genetic variants in gut immune function, barrier integrity, and microbiome composition influence host-microbiome interactions.

Metabolic dysfunction encompasses disruptions to cellular energy production, glucose metabolism, lipid processing, and mitochondrial function. Genetic variants across metabolic pathways have been studied in relation to chronic fatigue, Long COVID, and systemic illness.

Immune regulation refers to the biological mechanisms that control the magnitude and duration of immune responses, preventing both under-reaction to pathogens and over-reaction to self-tissue. Genetic variants in regulatory pathways may influence immune balance.

Oxidative stress occurs when the production of reactive oxygen species (ROS) exceeds the body's antioxidant capacity, damaging cells, proteins, and DNA. Genetic variants in antioxidant defence genes may influence individual susceptibility to oxidative damage.

Vascular function encompasses endothelial integrity, blood flow regulation, coagulation, and microcirculation. Genetic variants in vascular and endothelial genes have been studied in relation to Long COVID microclotting, cardiovascular disease, and autonomic dysfunction.

Antiviral defence encompasses the innate immune mechanisms that detect and respond to viral infections, including pattern recognition, interferon signalling, and direct viral restriction. Genetic variants in antiviral genes may influence susceptibility to viral illness and Long COVID.

Coagulation and fibrinolysis regulate the formation and dissolution of blood clots. Genetic variants in coagulation factors, natural anticoagulants, and fibrinolytic enzymes have been studied in relation to Long COVID microclotting, thrombosis, and cardiovascular risk.

The innate immune system provides the first, rapid response to pathogens through pattern recognition, interferon production, and phagocytosis. Genetic variants in innate immune sensors and signalling pathways may influence initial antiviral and inflammatory responses.

Detoxification pathways process and eliminate drugs, environmental toxins, and endogenous metabolites. Genetic variants in cytochrome P450 enzymes, Phase II conjugation enzymes, and transport proteins influence detoxification capacity and medication sensitivity.

Immune function encompasses the full range of immune system activities — from pathogen detection and elimination to immune memory and tolerance. Genetic variants across innate and adaptive immune pathways influence overall immunocompetence and disease susceptibility.

The antiviral response involves coordinated innate and adaptive immune mechanisms that detect, contain, and eliminate viral infections. Genetic variants in viral sensing, interferon production, and antiviral effector genes influence the effectiveness of antiviral immunity.

T cells are central to adaptive immunity, coordinating both cytotoxic responses against infected cells and helper functions that support B-cell antibody production. Genetic variants in T-cell development, activation, and function influence adaptive immune responses to infection and chronic disease.

Fibrosis involves excessive accumulation of extracellular matrix proteins (particularly collagen) in response to tissue injury, leading to scarring and organ dysfunction. Genetic variants in TGF-beta signalling, matrix remodelling, and inflammatory pathways influence fibrotic risk.

Hormonal dysregulation — including HPA axis dysfunction, sex hormone imbalances, and thyroid abnormalities — is frequently reported in Long COVID and ME/CFS. Genetic variants in hormone synthesis, receptor sensitivity, and endocrine signalling pathways may contribute.

Platelets are small blood cells that initiate clot formation upon vessel injury. Genetic variants in platelet activation receptors, aggregation pathways, and adhesion molecules influence platelet reactivity and thrombotic risk, relevant to Long COVID microclotting.

Antiviral defence mechanisms encompass the full complement of innate and intrinsic immune functions that restrict viral replication, from pattern recognition through to direct viral restriction factors. Genetic variants across these pathways influence viral susceptibility and clearance.

Medication sensitivity refers to individual differences in drug responses, including efficacy, side effects, and toxicity. Genetic variants in drug-metabolising enzymes, drug transporters, and target receptors underlie most pharmacogenomic differences relevant to chronic illness management.

Endothelial dysfunction refers to impaired function of the cells lining blood vessels, including loss of vasodilatory capacity, increased pro-inflammatory and pro-thrombotic signalling, and compromised vascular barrier integrity. It is a key feature of Long COVID vascular pathology.

Microcirculation refers to blood flow through the smallest vessels — capillaries, arterioles, and venules. Impaired microcirculation has been documented in Long COVID and may underlie exercise intolerance, tissue hypoxia, and multi-organ symptoms.

Macrophages are key innate immune effector cells that phagocytose pathogens, present antigens, and produce inflammatory cytokines. Dysregulated macrophage activation — including M1/M2 imbalance — has been implicated in Long COVID inflammatory persistence.

Autophagy is the cellular process of degrading and recycling damaged organelles, misfolded proteins, and pathogens. Genetic variants in autophagy pathway genes may influence cellular quality control, antiviral immunity, and susceptibility to protein aggregation diseases.

The interferon response is the primary antiviral signalling cascade, producing type I interferons that establish an antiviral state in host cells. Genetic variants in interferon production and signalling pathways are among the most strongly associated with COVID-19 severity.

Cellular energy production through mitochondrial ATP synthesis is fundamental to all physiological function. Impaired energy production is a central proposed mechanism in ME/CFS and Long COVID, manifesting as profound fatigue, post-exertional malaise, and exercise intolerance.

Tissue repair involves sequential phases of haemostasis, inflammation, proliferation, and remodelling following injury or infection. Genetic variants in growth factor signalling, extracellular matrix remodelling, and immune resolution pathways influence tissue repair quality and speed.

Neurotransmission encompasses the synthesis, release, receptor binding, and reuptake of neurotransmitters including dopamine, serotonin, norepinephrine, glutamate, GABA, and acetylcholine. Genetic variants in neurotransmitter pathways influence mood, cognition, and autonomic function.

Lipid metabolism encompasses the synthesis, transport, and oxidation of fats and cholesterol. Genetic variants in lipoprotein genes, lipid-metabolising enzymes, and cholesterol regulation pathways influence cardiovascular risk and cellular membrane biology relevant to viral infection.

Mucosal immunity provides specialised immune defence at epithelial surfaces including the respiratory tract, gut, and urogenital tract. Genetic variants in secretory IgA production, mucosal innate immunity, and epithelial barrier genes influence protection against pathogens entering through mucosal surfaces.

Antigen presentation — the process by which immune cells display peptide fragments to T cells — is central to adaptive immunity. HLA (MHC) gene variants are the strongest genetic determinants of autoimmune and infectious disease susceptibility.

The HPA axis is the central stress response system, regulating cortisol production in response to physiological and psychological stressors. HPA axis dysregulation — including hypocortisolism — is consistently documented in ME/CFS and Long COVID.

Vitamin D is both a nutrient and a hormone with broad immune-regulatory functions. Genetic variants in vitamin D synthesis, transport, receptor, and metabolism genes influence vitamin D status and immune response capacity, relevant to COVID-19 and Long COVID.

Natural killer (NK) cells are innate lymphocytes that rapidly kill virus-infected and tumour cells without prior antigen sensitisation. NK cell dysfunction has been documented in ME/CFS and Long COVID, and genetic variants in NK cell receptors and cytotoxic pathways influence NK cell activity.

The complement system is a cascade of plasma proteins that marks pathogens for destruction, directly lyses bacteria, and amplifies inflammation. Genetic variants in complement regulators have been implicated in COVID-19 severity and Long COVID vascular complications.

Immune activation refers to the processes by which immune cells become activated in response to pathogens, danger signals, or dysregulated stimuli. Chronic, persistent immune activation is a hallmark of Long COVID and ME/CFS.

Antioxidant defence systems protect cells from oxidative damage by neutralising reactive oxygen and nitrogen species. Genetic variants in NRF2, superoxide dismutase, glutathione peroxidase, and catalase influence individual antioxidant capacity.

Immune signalling pathways coordinate communication between immune cells and between immune and non-immune cells. Genetic variants in cytokine receptors, signal transducers, and downstream effectors shape immune response dynamics.

Pharmacogenomics studies how genetic variants influence responses to medications. Variants in drug-metabolising enzymes, transporters, and drug targets underlie individual differences in drug efficacy, dosing requirements, and adverse effect risk.

DNA repair mechanisms maintain genome integrity by correcting damage from oxidative stress, radiation, replication errors, and environmental mutagens. Genetic variants in DNA repair genes influence cancer susceptibility, ageing, and cellular resilience under chronic illness conditions.

Cellular signalling pathways translate extracellular signals into intracellular responses, coordinating cell growth, survival, differentiation, and immune function. Genetic variants in signalling pathway components influence immune regulation, inflammatory responses, and cellular homeostasis.

Epigenetics involves heritable changes in gene expression without DNA sequence changes, through DNA methylation, histone modification, and chromatin remodelling. Genetic variants in epigenetic regulators may influence gene expression patterns relevant to immune function and chronic illness.

The liver is the body's primary metabolic and detoxification organ, responsible for drug metabolism, lipid synthesis, glucose regulation, and protein production. Genetic variants in liver function genes may influence metabolic capacity and medication handling in chronic illness.

Tissue remodelling involves the dynamic turnover of extracellular matrix proteins and is governed by matrix metalloproteinases (MMPs) and their inhibitors (TIMPs). Genetic variants in these genes may influence fibrotic responses, tissue repair efficiency, and chronic illness progression.

Tissue damage triggers both oxidative and inflammatory responses, with genetic variants in damage-sensing, DNA repair, and antioxidant genes modulating how effectively the body detects and resolves cellular injury.

Type I interferons (IFN-alpha and IFN-beta) are critical antiviral cytokines whose dysregulation — either excessive or deficient — is associated with severe COVID-19, Long COVID, and autoimmune conditions. Genetic variants in interferon pathway genes may determine the IFN response amplitude.

The hypoxia response pathway coordinates cellular adaptation to low oxygen through HIF-1alpha and related transcription factors. Genetic variants in oxygen-sensing genes may influence how effectively the body maintains cellular function during hypoxic conditions such as respiratory illness.

Viral entry into host cells depends on receptor availability and protease activation. Genetic variants in ACE2, TMPRSS2, and related genes affect SARS-CoV-2 entry efficiency and may influence COVID-19 susceptibility, severity, and post-infection outcomes.

B cells produce antibodies and are critical for adaptive immunity. Genetic variants affecting B cell development, activation, class switching, and memory formation may influence antibody responses to infection and vaccines, and contribute to autoimmune conditions.

Lymphocytes coordinate adaptive immune responses through antigen-specific T and B cell activation, memory formation, and effector function. Genetic variants across lymphocyte development and activation pathways may influence immune competence, autoimmune risk, and post-infection immunity.

Sensory dysfunction encompasses altered pain processing, sensory hypersensitivity, anosmia, and dysautonomia-related sensory symptoms. Genetic variants in sensory receptor, ion channel, and central pain processing genes may influence sensory thresholds and chronic sensitisation.

The stress response system coordinates physiological adaptation to acute and chronic stressors through the HPA axis, sympathetic nervous system, and cellular stress response mechanisms. Genetic variants in cortisol signalling, glucocorticoid receptor, and heat shock protein genes modulate stress resilience.

Iron metabolism involves absorption, transport, storage, and utilisation of iron for haemoglobin synthesis and cellular processes. Genetic variants in iron metabolism genes affect iron homeostasis, with implications for both iron deficiency and iron overload conditions.

Genome stability is maintained by DNA repair pathways, cell cycle checkpoints, and telomere maintenance mechanisms. Genetic variants in these systems may influence cancer risk, cellular ageing, and the ability to recover from viral-induced genotoxic stress.

Antibody responses to infection and vaccination depend on B cell activation, affinity maturation, class switching, and plasma cell maintenance. Genetic variants in immunoglobulin, B cell, and antigen presentation genes may influence antibody titres and durability.

Neuroendocrine signalling integrates neural and hormonal signals to regulate metabolism, stress response, reproductive function, and homeostasis. Genetic variants in hypothalamic-pituitary axis, neuropeptide, and hormone receptor genes may influence multiple chronic illness symptoms.

Iron dysregulation encompasses both iron overload and functional iron deficiency, as well as ferroptosis — an iron-dependent form of regulated cell death. Genetic variants modulating iron sensing, ferritin production, and ferroptosis pathways have implications for chronic illness and Long COVID outcomes.

Neurodegeneration involves progressive loss of neuronal structure and function, driven by protein aggregation, neuroinflammation, mitochondrial dysfunction, and impaired clearance. Genetic variants influencing these mechanisms may affect neurodegeneration risk and post-COVID neurological outcomes.